- Home
- URG vs AQST Comparison
URG vs AQST Comparison
Compare URG & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- AQST
- Stock Information
- Founded
- URG 2004
- AQST 2004
- Country
- URG United States
- AQST United States
- Employees
- URG N/A
- AQST N/A
- Industry
- URG Precious Metals
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- AQST Health Care
- Exchange
- URG Nasdaq
- AQST Nasdaq
- Market Cap
- URG 280.5M
- AQST 272.9M
- IPO Year
- URG N/A
- AQST 2018
- Fundamental
- Price
- URG $0.79
- AQST $2.74
- Analyst Decision
- URG Strong Buy
- AQST Strong Buy
- Analyst Count
- URG 2
- AQST 5
- Target Price
- URG $2.45
- AQST $11.40
- AVG Volume (30 Days)
- URG 4.0M
- AQST 1.7M
- Earning Date
- URG 05-08-2025
- AQST 05-12-2025
- Dividend Yield
- URG N/A
- AQST N/A
- EPS Growth
- URG N/A
- AQST N/A
- EPS
- URG N/A
- AQST N/A
- Revenue
- URG $33,706,000.00
- AQST $54,228,000.00
- Revenue This Year
- URG N/A
- AQST N/A
- Revenue Next Year
- URG $251.38
- AQST $40.62
- P/E Ratio
- URG N/A
- AQST N/A
- Revenue Growth
- URG 200.09
- AQST 5.29
- 52 Week Low
- URG $0.55
- AQST $2.12
- 52 Week High
- URG $1.84
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- URG 56.15
- AQST 54.01
- Support Level
- URG $0.67
- AQST $2.22
- Resistance Level
- URG $1.00
- AQST $2.79
- Average True Range (ATR)
- URG 0.05
- AQST 0.19
- MACD
- URG 0.02
- AQST 0.04
- Stochastic Oscillator
- URG 44.48
- AQST 75.64
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.